Related references
Note: Only part of the references are listed.Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
Jing Wang et al.
JOURNAL OF HEPATOLOGY (2018)
Nucleos(t)ide analogue interruption: Alternative approach to intrahepatic set point for spontaneous control of HBV replication?
Yiqi Yu et al.
JOURNAL OF HEPATOLOGY (2018)
Reply to: Serum HBV pgRNA as a clinical marker for cccDNA activity Consistent loss of serum HBV RNA might predict the para-functional cure of chronic hepatitis B
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2017)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2017)
The role of quantitative hepatitis B surface antigen revisited
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2017)
Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection
Jun Luo et al.
JOURNAL OF VIROLOGY (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues
L. Jansen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
Marcelle Bottecchia et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
Jessica Liu et al.
HEPATOLOGY (2016)
In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection
Xiaonan Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
Overview of hepatitis B viral replication and genetic variability
Shuping Tong et al.
JOURNAL OF HEPATOLOGY (2016)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells
Thomas Vanwolleghem et al.
HEPATOLOGY (2015)
Present and Future Therapies of Hepatitis B: From Discovery to Cure
T. Jake Liang et al.
HEPATOLOGY (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy
Yi-Wen Huang et al.
ANTIVIRAL THERAPY (2015)
Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion During Treatment With Polymerase Inhibitors
Florian van Boemmel et al.
HEPATOLOGY (2015)
Distinct Seromarkers Predict Different Milestones of Chronic Hepatitis B Progression
Jessica Liu et al.
HEPATOLOGY (2014)
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
Lena Allweiss et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-nave, e antigen-positive patients
Michelle Martinot-Peignoux et al.
JOURNAL OF HEPATOLOGY (2013)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
Yi-Wen Huang et al.
ANTIVIRAL THERAPY (2010)
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
Tin Nguyen et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
Jerzy Jaroszewicz et al.
JOURNAL OF HEPATOLOGY (2010)
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients
Tassilo Volz et al.
GASTROENTEROLOGY (2007)
Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine
Tsuyoshi Hatakeyama et al.
HEPATOLOGY (2007)
Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients
Andreas Laras et al.
HEPATOLOGY (2006)
Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
Akinori Rokuhara et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients
DKH Wong et al.
HEPATOLOGY (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Share Paper
